Home monitoring is essential in modern medicine, but the cost-benefit analysis is essential for patients, insurance companies, and administrators. Domiciliary monitoring service by BIOTRONIK allows physicians to follow their patients remotely with cardioverter, reducing the need for clinic visits. Their use could result in a more efficient tracking reducing costs. The study included 303 patients who received defibrillator with or without resynchronization equipped with technology for home monitoring. After device implantation, patients were randomized to have the home monitoring function active versus disabled. After a two-year monitoring, remote monitoring significantly reduced the number of queries as well as the time for medical visits. The costs between the two groups were similar.
Hein Heidbuchel
2014-09-01
Original title: EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective on follow-up costs and net financial impact of remote monitoring in six European countries.
